feed,title,long_url,short_url
ðŸ’°Barrons,Sarepta Stock Tumbles 40%. Why the Biotechâ€™s Shares Are Sinking.,https://barrons.com/articles/sarepta-stock-price-earnings-failed-drug-trial-duchenne-muscular-dystrophy-dc458c3c?mod=RTA,
